🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this observational study is to compare the safety and effective...
Status
Unknown
Location
Fuwai hospital
Start Date
2022-04-01
Trial ID
NCT06039592
Multiple myeloma (MM) is an incurable malignancy and accounts for 1 percent...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-06-18
Trial ID
NCT03525678
Treatments Being Tested
Recently, there has been an emerging interest in how manipulating gut micro...
Status
Unknown
Location
Oxford University Department of Psychiatry
Start Date
2016-07
Trial ID
NCT02926508
Treatments Being Tested
The goal of this study is to learn if a new pre-workout supplement can impr...
Status
Completed
Location
Applied Science & Performance Institute
Start Date
2025-12-01
Trial ID
NCT07225608
Treatments Being Tested
This is a study to assess the efficacy and safety of pembrolizumab (MK-3475...
Status
Completed
Location
Multiple Locations
Start Date
2014-08-25
Trial ID
NCT02142738
Treatments Being Tested
This will be a randomized, double-blind, single-dose, three-period balanced...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-11-08
Trial ID
NCT01725685
Treatments Being Tested
The purpose of this research study is to find our if human amnion membrane ...
Status
Completed
Location
Wake Forest University Health Sciences
Start Date
2019-12-01
Trial ID
NCT03754218
Treatments Being Tested
A Phase 1a/1b, multicenter, open-label, non-randomized, dose-escalation, an...
Status
Completed
Location
Fox Chase Cancer Center
Start Date
2019-09-23
Trial ID
NCT04096638
Treatments Being Tested
This project is the stage of dose escalation, is was divided into single an...
Status
Completed
Location
China Japan Friendship Hospital
Start Date
2025-02-11
Trial ID
NCT06711991
Treatments Being Tested
This first-in-man trial forms the basis for potential clinical development ...
Status
Completed
Location
1313.1.1 Boehringer Ingelheim Investigational Site
Start Date
2011-11
Trial ID
NCT01480648
Treatments Being Tested